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ABSTRACT 
PROSPECTIVE RANDOMIZED STUDY COMPARING THE EFFICACY 
ANDCLINICAL PROFILE OF DEXMEDITOMIDINE AND FENTANYL AS AN 
ADJUVANT TO EPIDURAL ROPIVACAINE FOR POST OPERATIVE PAIN 
RELIEF IN SPINE SURGERIES 
 
BACKGROUND AND OBJECTIVES: 
Spine surgeries are commonly associated with moderate tosevere postoperative pain 
which remains a great challenge for the anaesthesiologist to treat it. Multimodal analgesic 
techniques like parenteral analgesics or regional analgesia are commonly practiced.Use of 
intrathecal opioids before surgical closure provide effective postoperative analgesia without 
any major side effects.This study was designed to compare the analgesic efficacy of Ropivacaine 
and Dexmedetomidine (RD) with Ropivacaine and Fentanyl (RF) by giving these drugs by epidural 
administration  in patients undergoing elective spine surgeries. 
MATERIALS AND METHODS: 
Prospective, randomized, double blinded study was conducted at Institute of 
Anaesthesiology and Critical Care, Rajiv Gandhi Government General Hospital, Chennai for 
a period of one yearafter ethical committee approval. 60 patients were randomly selected 
based on inclusion criteria and after obtaining written informed consent, patients were 
allocated into two equal groups.(RD & RF) and the data were analysed. 
RESULTS: 
The onset of sensory analgesia  was earlier in RopivacaineDexmeditomidine (RD) group 
(5.93±0.700 min) thanRopivacaine Fentanyl (RF) group(7.67±0.702 min), peak effect of 
analgesia was 12.07min for RD group and 13.13min for RF group, mean duration of analgesia 
was significantly longer in RD group than RF group(349.80± 8.124min vs 298.20±4.77min). 
Both groups showed haemodynamic stability. Visual Analogue Scale score between group 
RD and RF was1.79 and 2.31. Rescue analgesic requirement was less with RD group. Mean 
sedation score at various time intervals was significant between these groups. No episode of 
respiratory depression was noted in RD group. 
CONCLUSION: 
Concluded  from  this study that epidural route provided adequate analgesia in both 
groups. However,Dexmedetomidine seems to be a better alternative toFentanyl  as it 
provides early onset and establishment of sensory anesthesia, prolonged postoperative 
analgesia, lowerconsumption of postoperative rescue analgesia,comparablestable 
hemodynamics, andmuch better sedation levels. 
KEYWORDS: Epidural analgesia, Ropivacaine,Dexmeditomidine, Fentanyl. 
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INTRODUCTION 
Spine surgeries are commonly associated with moderate to severe 
postoperative pain which is directly related to the invasiveness of the 
procedure. A large incision and manipulation of multiple vertebrae in spine 
surgeries contribute postoperative pain which remains a great challenge for 
the anaesthesiologist to treat it. Multimodal analgesic techniques like 
parenteral analgesics or regional analgesia are commonly practiced1. 
Conventional methods like intravenous  or intramuscular analgesics are  
followed using opioids and non-steroidal anti-inflammatory drugs 
(NSAID’s).The opioids, though  potent analgesics,  are associated with 
postoperative respiratory depression ,  nausea and vomiting, whereas less 
potent NSAIDs have limited use due to their renal and gastrointestinal side 
effects.  The use of intrathecal opioids before surgical closure also provide  
effective  postoperative  analgesia  without any major side effects2. 
 The use of   local  anaesthetics with adjuvants like opioids and alpha 
agonists through an epidural catheter placed  intraoperatively  under direct 
vision at the end of the procedure, is an effective alternative method for 
controlling postoperative pain 
Good perioperative analgesia is  important  to attenuate the surgical 
stress response. Epidural analgesia reduces the adverse physiological 
responses to surgery like hyperactive autonomic nervous system response, 
cardiovascular stress response, tissue breakdown, high metabolic rate, 
pulmonary dysfunction and immune system dysfunction3. 
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By placing a catheter in the epidural space, continuous  anaesthesia  
can be maintained for a long period of time . Epidural catheter can also be 
used to provide postoperative analgesia with lower concentrations of local 
anesthetic drugs alone or with adjuncts. Early postoperative mobilization and 
rehabilitation with minimal associated pain and discomfort is the most 
desirable feature in modern orthopedic surgeries3. This can be done by using a 
local anesthetic with lesser propensity of motor block. 
Ropivacaine, the newer amide local anesthetic with minimal 
cardiovascular, central nervous system toxicity as well as  lesser propensity of 
motor block has been used in this study. Traditionally opioids have been used 
as  adjuvant to achieve the desired anesthetic effect with a  lower dose of 
local anesthetic and superior analgesia. 
Dexmedetomidine, is a new addition to the class of alpha-2 agonists, 
and a close congener of Clonidine, has been used for this purpose with many 
beneficial effects. Dexmedetomidine, is an imidazoline derivative, which is 
1600 times more selective for alpha-2 receptors than alpha-1 receptors. It acts 
on both pre- synaptic and post- synaptic sympathetic nerve terminals and on 
the central nervous system thereby decreasing the sympathetic outflow and 
Norepinephrine release causing sedative, anti-anxiety, analgesic, 
sympatholytic effects. The anti nociceptive action is due to its effect at the 
spinal cord alpha -2 receptors4. 
This study was designed to compare the analgesic efficacy of 
Ropivacaine with Dexmedetomidine  and Ropivacaine with Fentanyl  by their 
epidural administration  in patients undergoing elective spine surgeries.  
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DEFINITION OF PAIN 
 
Pain is “an unpleasant sensory and emotional experience associated 
with actual or potential tissue damage or described in terms of such damage"5. 
 
CLASSIFICATION OF PAIN:  
1) acute pain.  
2) chronic pain. 
Acute pain has feature of sudden onset and recedes during healing 
process. This  pain is considered as good pain because it  serves as an 
important protective mechanism, an example of this is the  withdrawal reflex.  
Chronic pain which means inflammatory and neuropathic pain, is 
considered as bad pain since it persists for a longtime after recovery from 
injury. This is refractory to common analgesics such as NSAIDs and opioids. 
Chronic pain results from nerve injury which includes diabetic neuropathy, 
toxin induced nerve injury and ischemia.  
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 POST OPERATIVE PAIN6  
During surgical tissue injury there is a release of inflammatory 
mediators like bradykinin, prostaglandins, serotonin and histamine. This 
activates the peripheral nociceptors and transmits the impulses through A 
delta and C fibers to the dorsal horn of spinal cord . This pain when 
uncontrolled, postoperatively ,has detrimental effects which are both acute 
and chronic. The predominant  neuro endocrine response to pain includes  the 
hypothalamo - pituitary -adrenocortical  and  the sympathoadrenal 
interactions which result in increased release of catecholamines and catabolic 
hormones like cortisol, increased sympathetic tone and decreased anabolic 
hormones. The  extent of stress depends upon the type of anaesthesia and 
intensity of the surgical injury. 
EFFECTS OF POST OPERATIVE PAIN:  
(i) Cardiovascular system: The uncontrolled post operative pain 
causes hypertension, tachycardia, myocardial irritability and increased 
systemic vascular resistance. Cardiac  output increases in most of the normal 
patients. The myocardial oxygen demand increases which may  precipitate  
myocardial ischemia.   
(ii) Respiratory system: The minute ventilation increases due to 
increase in oxygen consumption and with the carbon dioxide production 
which ultimately results in  increase in the work of breathing more important 
in patients with underlying lung disease. Abdominal and thoracic incisions 
compromise the pulmonary function because of splinting and decrease  the 
tidal volume and functional residual capacity, this leads to atelectasis, intra 
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pulmonary shunting and hypoxemia. The decreased vital capacity impairs the 
ability to cough and clear secretions. 
(iii) Gastro intestinal system: The increased sympathetic tone, 
increases sphincter tone, decreases intestinal and bladder motility and causing 
ileus and urinary retention. Stress ulcers which occur due to hyperacidity may 
worsen the effects of pulmonary aspiration. 
(iv)Endocrine effects: Stress increases the catabolic hormones like 
catecholamines, cortisol and glucagon and decreases the anabolic hormones 
like insulin and testosterone. This results in negative nitrogen balance, 
hyperglycaemia, increased lipolysis, sodium and water retention.  
(v) Haematological effects:  This includes increased platelet 
adhesiveness, decreased fibrinolysis and hypercoagulability of blood. 
(vi) Musculo skeletal system effects: Restricted  mobility due to pain 
leads to pressure sores and  an increased risk for deep vein thrombosis. 
(vii) Psychological effects: Sleep disturbance, anxiety, fatiguability 
and depression. 
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ANATOMY OF EPIDURAL SPACE7 
 
 
VERTEBRAL COLUMN 
The vertebral column consists of 33 vertebrae (7 cervical, 12 thoracic, 
5 lumbar, 5 fused sacral and 4 coccygeal) and four curves. The cervical and 
lumbar vertebrae have curves which are convex anteriorly and the thoracic 
and sacral vertebrae are convex posteriorly. These curves have a significant  
influence on the spread of local anaesthetics in the epidural and subarachnoid 
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space. The vertebal column is bound together by several ligaments which give 
stability and elasticity to it.  
LIGAMENTS 
1) Supraspinous ligament .It is a strong fibrous cord which connects the apices of 
spinous processes from sacrum to C7.It then extends to external occipital 
protruberance ,where it is called as the ligamentum nuchae. 
2) Interspinous ligament – Thin membranous ligament which connects the 
spinous processes and blends anteriorly  with ligamentum flavum and 
posteriorly with supraspinous ligament. 
3) Ligamentum flavum – called as ‘ the yellow ligament’, comprises of yellow 
elastic  fibres that connects adjacent lamina , it runs from the caudal edge of 
the vertebra above to the cephalad edge of the lamina below. 
4) Longitudinal ligaments – the anterior and posterior longitudinal 
ligaments bind the vertebral bodies together. 
The spinal cord  is continuous above with the medulla oblongata, it 
begins at the level of the foramen magnum and ends below as the conus 
medullaris ,a thin thread filum terminale is attached to the coccyx. It ends the 
lower border of L3 in newborn and lower border of L1  in adult .It is 
cylindrical in shape, flattened in the lumbar region with the length of45 cms.  
There are totally 31 pairs of symmetrically arranged spinal nerve roots,  
eight Cervical ,  twelve Thoracic , five Lumbar , Sacral  and one Coccygeal 
root . The cauda equina is formed by elongation of the nerve roots of lumbar 
and sacral region before they exit from the inter vertebral foramen.  
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SPINAL CORD STRUCTURES8 
 
1) Epidural (extradural) space – It lies between the dura mater and 
periosteum. It extends from the foramen magnum to the sacral hiatus. It is a 
triangular space in cross-section, with two larger posterolateral and a small 
anterior compartments. It also extends through the spinal foramina (as the 
nerve roots exit) laterally. The depth of the epidural space is  3–5 cm from the 
skin, it is bounded by ligamentum flavum  posteriorly , posterior longitudinal 
ligaments anteriorly and laterally by pedicles and  intervertebral foramina. 
The extradural space consists of adipose tissue, lymph vessels, arteries 
and venous plexus. The epidural space is widest in the midline and tapers off 
laterally. It is 5-6 mm in the mid lumbar region, whereas, in the thoracic 
region it is 3-5mm. Ligamentum flavum is the key landmark in epidural 
catheterization. It is composed mainly  of elastic fibers, providing a unique 
clue for epidural needle placement using loss of resistance (LOR) technique. 
2) Subdural space – It is the potential space between the arachnoid 
mater and duramater which contains thin serous fluid. 
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3) Subarachnoid space - It is the space between the arachnoid mater 
and piamater which contains cerebrospinal fluid (CSF), spinal nerves, 
trabecular network between the two membranes, blood vessels that supply the 
spinal cord, lateral extensions of the piamater and dentate ligaments. 
Although the spinal cord ends at the lower border of L1 in adults, the 
subarachnoid space continues up to the S2segment. 
4) Dura mater –It contains two layers of dense fibro elastic membrane 
in which the outer layer attaches to the foramen magnum and the inner layer 
continues as cerebral dura. The dura ends at the second sacral segment. It 
attaches to the coccygeal periosteum and covers the filum terminale. 
Anteriorly the dura is attached to the posterior longitudinal ligament and 
extends around the nerve roots laterally but it is free posteriorly. 
5) Arachnoid mater – It is a delicate, nonvascular thin membrane 
closely lining the duramater. The arachnoid  functions as the principal barrier 
to drugs crossing in and out of the CSF and is estimated to account for 90% of 
resistance to the drug migration. 
6) Pia mater –A Highly vascular connective sheath that closely covers 
the spinal cord. The anterior part is thickened (linea splendens) and attached 
to the dura laterally (ligamentum denticulatum). Posteriorly, attaches to the 
dura by an incomplete sheet of pia (posterior subarachnoid septum). Inferiorly 
it is attached to the coccyx is through filum terminale which is its 
continuation. 
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MECHANISM OF ACTION OF LOCAL ANESTHETICS9 
Local anaesthetics act by preventing the activation of the sodium 
channel by binding to them  in the inactivated state. The Development of 
action potential is prevented by blocking the movement of sodium ions into 
the cell membrane. This membrane stabilization property is the unique quality 
of local anaesthetics where  repeated nerve stimulation will not affect the 
resting membrane potential. 
MECHANISM OF ACTION OF LOCAL ANAESTHETICS IN 
NEURAL BLOCKADE 
In the dorsal horn neurons, local anaesthetics act by blocking both  
sodium and potassium ion channels  and thus inhibiting the generation of 
nociceptive electrical activity and thereby propagation of pain (noxious) 
signals. Similarly it acts on the ventral horn neurons to produce the motor 
blockade. Centrally administered local anaesthetics produce an intense 
analgesic action by blocking the Ca+ channels in the spinal cord. This may 
lead to resistance to electrical stimulation from afferent nerves carrying pain 
signals. Apart from these actions, local anaesthetics given through intrathecal 
route indirectly inhibit release of neurotransmitters like substance P, involved 
in pain signal processing. This leads to blockade of neurotransmitters like 
glutamate, calcitonin gene-related peptide (CGRP), neurokinin-1 and -2 
(NK1, NK2) at the presynaptic level. Therefore local anaesthetics given 
intrathecally can indirectly inhibit the transmission of pain signals. 
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ORDER OF BLOCKADE IN REGIONAL ANESTHESIA9 
The block and recovery of sensory fibers occur in this order 
B-fibers -Preganglionic sympathetic fibers are most sensitive to local anaesthetic 
C fibers – cold sensation 
A ∂  – pin prick 
A β  – touch 
Aα - Vibration, proprioception and innervation to skeletal muscles 
 Aα are less sensitive to local anaesthetics 
SITE OF ACTION 
The precise mode of action of an epidural drug has not been identified. 
The proposed  sites of action are24: 
 Spinal roots within the dural root sleeves as they traverse epidural 
space. 
 Dorsal root ganglia 
 Substance of spinal cord 
INDICATIONS FOR EPIDURAL ANAESTHESIA  
Epidural anaesthesia can be used for a variety of surgeries and 
conditions extending from the neck to the foot.   
1) Prolonged  orthopaedic surgeries like major hip/knee surgery, repair of 
pelvic fractures etc.   
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2) Obstetric,   gynaecological surgeries and labour analgesia. 
3) Urological surgeries involving prostate, bladder and ureters. 
4) Epidural analgesia for upper abdominal procedures, thoracic 
procedures. 
5) Paediatric caudal for lower abdominal  surgeries and lower limb 
surgeries.  
CONTRAINDICATIONS  
 (A)    Absolute contraindication 
 Patient refusal. 
 Coagulopathy /Platelet count <80,000 cells/mm3 
 Sepsis, infection at the puncture site 
 Increased intracranial pressure. 
 Severe hypovolemia,  
 Severe aortic& mitral stenosis 
 (B)   Relative contraindication 
 Uncooperative patient 
 Severe spine deformities 
 Demyelinating lesions 
 Hypertrophic obstructive cardiomyopathy 
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COMPLICATIONS OF EPIDURAL ANAESTHESIA 
Major complications associated with epidural anaesthesia are 
1) Direct trauma to the nerves 
2) Systemic toxicity associated with inadvertent intravascular 
injection 
3) Subdural injection of drugs,  
4) Total spinal anaesthesia 
5) Epidural abscess and meningitis. 
Minor complications include backache, nausea, vomiting, postdural 
puncture headache, pneumocephalus, shivering .and urinary retention. 
 14
PHARMACOLOGY OF ROPIVACAINE(10) 
Stucture of  Ropivacaine - Ropivacaine Hydrochloride: (S)-N-(2,6-
dimethylphenyl)-1-propylpiperidine2carboxamide hydrochloride. 
 
Molecular Formula c17h26n2o2.hcl.h2o: Molecular Weight 328 
Ropivacaine belong to amide group of local anaesthetic drug with both 
anaesthetic and analgesic properties. At high doses it produces anaesthesia 
and at lower doses it produces analgesia (sensory block) due to its differential 
blocking effect on nerve fibers. It belongs to a different local anaesthetic 
group,  called the pipecoloxylidides,  was synthesized in 1957.  
Ropivacaine is a local anaesthetic with increased duration of action, 
which is similar in structure to Bupivacaine. In contrast to Bupivacaine, 
Ropivacaine a pure S (-) enantiomer11, has reduced toxicity and at the same 
time improved sensory and motor block. It acts on different ion channels like 
sodium, potassium and calcium with different affinity that leads to greater 
reduction in neuronal toxicity and cardiovascular side effects. Ropivacaine is 
derived as a pure form of S (-) enantiomer from propivacaine, the parent 
molecule with chiral property. It belongs to  pipecoloxylidides group of local 
anaesthetics with the piperidine nitrogen atom having a propyl group.11               
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Ropivacaine causes reversible blockade of impulse propagation by 
inhibition of sodium ion influx in nerve fibres. It inhibits potassium channel 
in a dose-dependent manner, because of less lipid solubility than Bupivacaine, 
it minimally penetrates the large myelinated  Aα motor fibres, explains its 
more specific action on the pain-transmission through A and C nerves rather 
than A α fibres (motor function). 
Ropivacaine has a lesser propensity for cardiac and CNS adverse 
effects because of its stereo selective property. Its efficacy is similar to that 
of  Levo Bupivacaine and Bupivacaine in blocking peripheral nerve, but when 
given neuraxially (epidural or intrathecal) it is less potent than Bupivacaine. 
It is also associated with  lower grade motor blockade when compared to 
Bupivacaine. Because of its lower grade of motor blockade, there is reduced 
potential for CNS and cardiac adverse effects hence, it is a new agent of 
choice for regional anaesthesia12.  
PHARMACOKINETICS10 
The plasma concentration depends on the dose, route of administration and 
vascularity of the injection site. Ropivacaine follows linear pharmacokinetics Cmax 
is proportional to the dose. When given through epidural route its absorption is 
biphasic (t1/2 is 4.2 hrs) and complete. Elimination of Ropivacaine mainly depends 
on absorption which is the rate limiting step. The drug has longer half life when 
given epidurally. When given in the intravenous route   it has the terminal half life 
about1.8hrs. 
Ropivacaine is highly protein bound particularly to α1-acid 
glycoprotein and only 6%  is present as unbound fraction. It crosses the 
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placenta easily and degree of plasma protein binding in fetus is less when 
compared to mother. 
METABOLISM10 
It is metabolized mainly in liver by aromatic hydroxylation by the 
enzyme cytochrome P450-1A . By IV route, a large amount of the drug for 
about 86% is excreted in urine.t Out of this  only, 1% is  excreted as 
unchanged fragment. The important metabolite  3-hydroy-ropivacaine  is 
excreted after conjugation. The PPX (2’, 6’-pipecoloxylidide) has longer t1/2 
and lower clearance after infusion by epidural. After epidural infusion  N-de-
alkylated metabolite of Ropivacaine  and 3-OH-Ropivacaine are the major 
metabolites excreted in the urine.  
Clearance – unbound Ropivacaine – 13.94L/h/Kg 
Clearance – Total Ropivacaine – 0.555L/h/Kg 
Volume of distribution – 65.57L/min 
Terminal t1/2 of Ropivacaine - 3.3hrs 
Terminal t1/2 of PPX – 17.8 hrs 
CONTRAINDICATIONS 
 Hypersensitivity reactions to any amide group of local anaesthetics. 
 Intravenous regional anaesthesia. 
 Hypovolemic patients. 
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PRECAUTIONS 
 Accidental intravenous administration results in cardiac arrest and 
convulsions. 
 Retro bulbar block because of less clinical evidence. 
 Patient with poor general condition 
 Liver disease. 
 Kidney dysfunction. 
 Acute porphyria 
DRUG INTERACTIONS 
 Duration and intensity  of block will not be altered by adding adrenaline. 
 Additive effects with other local anaesthetics and Anti-arrhythmic drugs. 
 With Fluvoxamine, Verapamil will prolong the half life. 
 With  Ketaconazole reduces the plasma clearance by 15 %. 
INDICATIONS 
 Epidural block for surgical anaesthesia in abdominal surgeries, pelvic, 
lumbar, lower limb and Caesarean section. 
 Paediatric caudal block 
 Spinal anaesthesia. 
 Nerve blocks. 
 Field and infiltration blocks. 
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DOSAGE AND ADMINISTRATION10 
 Caudal – 1mg/kg 0.2% produces a block level below T12. 
 Epidural block with 6-15 ml of 0.2% Ropivacaine provide adequate 
analgesia. 
 Spinal – 2-3ml of 0.75 % ( 7.5mg/ml) . 
Surgical 
anaesthesia 
 
Concen-
tration 
mg/ml 
Volume 
(ml) Dose(mg) 
Onset 
(minutes) 
Duration 
(hours) 
Lumbar 
epidural, pelvic, 
and lower limb 
surgeries 
5.0 15-30 75-150 15-30  
2-4 
7.5 15-25 113-188 10-20 3-5 
Nerve blocks 
5.0 35-50 175-250 15-30 5-8 
7.5 10-40 75-300 10-25 6-10 
Field block 
5.0 1-40 5-300 1-15 2-6 
7.7 1-30 7.5-225 1-15 2-6 
PREGNANCY AND LACTATION: 
There are not many well documented studies in pregnant and nursing 
mothers. 
ADVERSE EFFECTS: 
Hypersensitivity reactions, Hypotension, bradycardia, vomiting, urinary 
retention,  
CNS toxicity, cardiac toxicity, spinal cord dysfunction such as anterior 
spinal artery syndrome, arachnoiditis, cauda equina syndrome - less common 
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EPIDURAL ADMINISTRATION13: 
Ropivacaine is less potent than Bupivacaine when equal volumes of similar 
concentration administered . Hyperbaric solutions have faster onset and a more 
reliable block with good recovery, because of the variability in spread and duration of 
the block ,but hyperbaric Ropivacaine solutions are not available. When administered 
with opioids, Ropivacaine not only reduces the total dose of local anaesthetic but also 
causes significant prolongation in the duration of complete and effective analgesia 
without increase in the duration of motor block.3 
The potency of Ropivacaine in relation to Bupivacaine is 2/3rd with regard to 
sensory block and 1/2 with regard to motor block. 
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PHARMACOLOGY OF DEXMEDITOMIDINE 
HISTORY14  
Historically α2-agonist were used in treating hypertensive patients and 
with drawl symptoms of alcohol and drug abusers. The α2-agonists provide 
sedation, anti-anxiety, hypnosis, analgesia and also inhibit sympathetic 
system.  
Dexmedetomidine is more selective for α2 receptors with 1600 times 
greater affinity for α2  than  α₁ receptor. It was introduced in 1999 as a short 
term sedative agent in ICU for adult patients on mechanical ventilation. But 
now it is widely used as a sedative, adjuvant analgesic for various diagnostic 
procedures. 
PHYSIOCHEMICAL CHARACTERISTICS15 
Dexmedetomidine is the d-enantiomer of medetomidine, belong to 
imidazole subgroup of α2 agonist. The receptor specificity ratio 1600:1(α₂: 
α₁),  freely soluble in water. 
STRUCTURE OF DEXMEDETOMIDINE 
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PHYSIOLOGICAL FUNCTIONS OF ALPHA 2 RECEPTORS 
Alpha 2a  – Presynaptic feedback inhibition of Norepinephrine release 
Hypotension 
Analgesia 
Sedation 
Inhibition of epileptic seizures 
Alpha 2b –  Hypertension 
Placental angiogenesis 
Analgesic effect of nitrous oxide  
 Alpha 2c –Feedback inhibition of adrenal catecholamine release 
Analgesic effect of moxonidine 
Modulation of behaviour 
 MECHANISM OF ACTION  
1) Activates the inhibitory action of G proteins which leads to decrease in 
cyclic AMP. 
2) Activate G proteins which directly act on membrane bound ion 
channels, more do on   potassium channels. 
3) Activates Nitric Oxide, Cyclic GMP pathway by inhibiting the release 
of Noradrenaline     within neuronal tissue.  
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It causes hypotension and bradycardia in the dorsal motor complex of 
medulla.  Its action on the locus coeruleus leads to analgesia and sedation. 
High density of receptors are present  in the vagus nerve, intermediolateral 
column , substantia gelatinosa, dorsal horn of the spinal cord and also in 
primary sensory neurons. 
ΑLPHA2  ADRENOCEPTOR(14) 
 
 The α2 receptors are G-protein coupled receptors present in the 
transmembrane region of central and peripheral nervous system, more particularly 
at the autonomic ganglion of pre synaptic and post-synaptic regions. Endogenous 
agonists such as nor epinephrine and exogenous agonists such as clonidine acts on 
these receptors and inhibit the enzymes, adenylcyclase and phospholipase C .This 
results in inhibition of calcium ion (Ca+) entry and facilitates opening of 
potassium ion (K+) channels outwards, and  leads to hyperpolarization. 
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PHARMACOKINETICS 
Dexmedetomidine undergoes rapid distribution and extensive 
metabolism in liver and is excreted in urine and feces. About 41% undergoes 
conjugation  and 21%    n-methylation 21%,or hydroxylation followed by 
conjugation. It has protein binding capacity of 94%  to serum albumin and α1-
glycoprotein, with half-life (t½) of 6 minutes and elimination t½ of about 2 
hours; and volume of distribution around 118 litres. Clearance is about 39 L/h 
for a 72 kg person. 
DISTRIBUTION  
Dexmedetomidine has a  plasma  protein binding capacity of 94% 
which is constant for different concentration in plasma which is similar for 
both sexes. Patients with decompensated  liver disease have decreased protein 
binding capacity. 
METABOLISM 
There is an almost complete biotransformation of Dexmedetomidine 
with very little unchanged amount which is excreted in urine and feces. 
Biotransformation occurs through both direct glucuronidation  and 
cytochrome P450 mediated metabolism. The major metabolic pathways are: 
1) Direct N-glucuronidation  gives rise to inactive metabolites 
2) Aliphatic hydroxylation (mediated primarily by CYP2A6) gives rise to 
3-hydroxy-Dexmedetomidine, the glucuronide of 3-hydroxy-
Dexmedetomidine, and 3-carboxyDexmedetomidine 
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3) N methylation of Dexmedetomidine gives rise to generate 3-hydroxy 
N-methyl-Dexmedetomidine, 3-carboxy N-methyl-Dexmedetomidine, 
and Dexmedetomidine-N-methyl O-glucuronide. 
ELIMINATION  
The Dexmedetomidine has a terminal elimination half-life (t½) of 
approximately 2 hours and a clearance of approximately 39 L/h. 
AGE AND GENDER 
Dexmedetomidine hydrochloride does not show any variation in 
pharmacokinetics in both  sexes and  age groups. 
PEDIATRICS 
The researches are minimal in children regarding the pharmacokinetics. 
HEPATIC IMPAIRMENT 
Hepatic clearance values are lower, depend  on the  degree of  hepatic 
derangement and the    dosage  is to be reduced depending on variations in 
liver function tests. 
RENAL IMPAIRMENT 
Dexmedetomidine hydrochloride pharmacokinetics do not vary in 
patients with severe renal impairment (creatinine clearance < 30 mL/min)  
when compared to healthy subjects. Since the metabolites are excreted in 
urine, they may accumulate on long term infusion. 
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DRUG INTERACTIONS 
There is no evidence of cytochrome P450 mediated drug interactions 
that are likely to be of clinical relevance. When administered with 
anaesthestics, sedatives, hypnotics or opioids, it may lead to enhancement of 
their effects, so, they may need a  reduction of dosage. It may have an 
additive effect with vasodilators and negative chronotropic agents. Midazolam 
and Propofol administration with Dexmeditomidine may lead to increased 
incidence of bradycardia and hypotension, hence more caution is required. 
PREGNANCY, LABOUR AND LACTATION 
There are no adequate and well controlled trials. Hence  it should be 
used with caution. 
ADVERSE EFFECTS 
Most frequently observed side effects are hypotension, dry mouth, 
bradycardia  and nausea. Other effects are fever, arrhythmias, AV block, extra 
systoles, pulmonary oedema, dizziness, headache etc., 
ALPHA 2 ANTAGONIST 
Atipamezole16 
Atipamezole, a selective alpha 2-adrenoceptor antagonist . Intravenous 
Atipamezole reverses the sedation and sympatholysis in dose a dependent 
manner . Due to the similar elimination half-lives for both agonist and the 
antagonist, the clinical effect of Dexmedetomidine after reversal by 
Atipamezole is very minimal. Therefore the Dexmedetomidine provides 
hypnosis and sedation in titrated doses and reversed readily by Atipamezole. 
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PHARMACOLOGY OF FENTANYL9 
 Fentanyl is a phenyl piperidine derivative of synthetic opioid agonist 
that is structurally related to Meperidine. Its analgesic efficacy is 100 times 
more potent than Morphine. It is available as a colorless solution in 2 and 10 
ml ampoules with 50µg/ml. Its chemical structure is given as follows:  
 
PHARMACOKINETICS 
A    single dose of Fentanyl has a more rapid onset  and shorter 
duration of action than Morphine. The more rapid  onset of action is due to  
its high lipid solubility, 500 times more lipid soluble than Morphine. The 
shorter duration of action is  due to rapid redistribution to tissue sites such as 
fat, skeletal muscles. Plasma and CNS concentration falls below an effective 
level during rapid distribution phase at smaller doses  (1-2µg/kg).The 
duration of action is prolonged while using higher doses or with frequent 
administration. In these circumstances ,the plasma concentration is high even 
after the distribution phase is complete. Recovery from the drug effect 
depends  upon  the slow elimination of the drug (terminal half life-3.5hrs).The 
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lungs serve as inactive storage site with up to 75%  of the drug undergoing 
first pass pulmonary uptake. 
METABOLISM 
It is metabolized in the liver by N-demethylation producing 
Norfentanyl,  Hydroxy propionyl Fentanyl and Hydroxypropionyl 
Norfentanyl. Norfentanyl  is the principal metabolite in humans and excreted 
by kidneys. 
CLINICAL USES 
It is administered in a wide range of clinical doses .Low dose  1-
2µg/kg IV produces analgesia. In dose of 2-20µg /kg IV may be used as an 
adjuvant to inhalational anesthetics to blunt circulatory responses to direct 
laryngoscopy and sudden changes in the level of surgical stimulation. 
Administered in dose of 1.5 to 3 µg/kg IV, 5 minutes before induction 
decreases the requirement of inhalational anesthetics and subsequent opioid 
requirement in the postoperative period. Large doses up to 50 -150 µg/kg IV 
produces surgical anaesthesia. It can be used to augment effects of local 
anesthetics in spinal and epidural analgesia at dose of 10-25µg and 25-100µg 
respectively. 
ADVANTAGES 17 
Stable haemodynamics which are due to: 
1) Lack of myocardial depressant effect 
2) Absence of histamine release 
3) Suppression of stress response to surgery 
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SIDE EFFECTS 
1) Bradycardia  
2) Myoclonus  
3) Dose dependent respiratory depression . 
4) Unconsciousness, muscular rigidity of the chest wall - at higher 
doses 
DRUG INTERACTIONS 
1) Potentiate the effects of Benzodiazepines   
2) Decrease the dose requirements of Propofol.  
3) Opioid  Benzodiazepine synergism with respect to hypnosis and 
depression of  ventilation 
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REVIEW OF LITERATURE 
1. Georgios Ekatodramis et al.(2002),18 studied in 23 patients in 
spine deformity surgeries. These introduced intraoperatively two epidural 
catheters  through which bolus of  Bupivacaine 0.0625% was injected 
followed by continuous infusion of  Bupivacaine 0.0625%, Fentany l-2 μg/ml 
and Clonidine 3 μg/ml and administered at a rate of 10 ml/hr through each 
catheter for 48 hr. They studied pain score, sedation level, motor block and 
side-effects.  They concluded that postoperative epidural analgesia by means 
of a double catheter was an effective technique to control pain after spine 
deformity surgery and associated with a low incidence of side-effects 
2..RJ.Kumar, KV.Menan, TC.Ranjith et al.,(2003)19 did a   
retrospective study of the role of postoperative epidural analgesia in major 
spinal surgical procedures. They selected 74 patients who were undergoing 
spinal surgery and in those patients, after the end of surgery  before the 
wound closure ,20 gauge epidural catheter was placed under direct vision 2.5 
cm away from the main surgical incision. Post operatively those patients 
received various combination drugs such as Bupivaine with Fentanyl, 
Bupivacaine with Morphine and, Bupivaine with Buprenorphine.They 
concluded that Epidural analgesia was a safe and extremely useful modality in 
spinal surgery. All the drug combinations used in this study seemed to be 
equally effective in controlling postoperative pain. 
 3.André Gottschalk et a.,l (2004)20 conducted a prospective 
randomized, placebo-controlled, double-blind study in 30 patients undergoing 
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major spinal surgeries by giving an infusion of 12 ml/h Ropivacaine 0.1% 
(group R), and 12 ml/h saline (group N) after an initial bolus of 10 ml of the 
respective study solution. Both the groups were connected  with intravenous 
PCA pump by the central venous line, using 1.5 mg of the Mu-receptor 
agonist Piritramide. The results obtained were as follows; continuous epidural 
infusion with 0.1% Ropivacaine resulted in significant reduction in VAS 
values during the whole study period. Satisfaction was higher in patients 
receiving epidural Ropivacaine. They  concluded that significant pain relief 
and lower opioid requirement during a postoperative time of 72 hrs after 
lumbar spinal surgery when compared with intravenous PCA. 
 4. Oriol-Lopez, Maldonado Sanchez et al., 21 (2008) conducted a 
prospective, descriptive study in 40 patients undergoing abdominal surgery 
under epidural anaesthesia. Dexmedetomidine at a dose of 1 µg/kg added to 
epidural Lignocaine produced Ramsay sedation score of 3 in 17% of the 
patients  in 5 minutes, 90% of the patients had sedation score  of  3-4  from 
15-90 minutes, 4 % of patients had sedation score of 5 from 30-60 minutes. 
They concluded that adequate sedation (Ramsay sedation level of 3-4) was 
maintained between 10-120 minutes with a single bolus epidural dose of 
Dexmedetomidine 
5.Salgado PF et al (2008)et al22 conducted a  prospective randomized 
control study in 40 patients undergoing  varicose vein and hernia surgeries 
under epidural anaesthesia. They compared 0.75% Ropivacaine (20 ml)  with  
0.75% Ropivacaine (20 ml) and Dexmedetomidine 1µg/kg. They observed the 
addition of  Dexmedetomidine did  not affect the onset time or upper level of 
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anaesthesia. However sensory and motor block duration was prolonged, post 
operative analgesia was longer and more intense motor block. BIS scores 
were lower in Dexmedetomidine group. There was no difference in incidence 
of hypotension and bradycardia.  Occurrence of side effects namely vomiting, 
shivering and respiratory depression(spo2 <90% ) was low and similar 
between the groups . They concluded that there exists a synergism between 
epidural Dexmedetomidine and Ropivacaine without additional side effects. 
6. Elhakim M, Abdelhamid D et al., (2010)23 conducted a 
comparative study in 50 adults who underwent thoracic surgery with epidural 
analgesia and one lung ventilation. They concluded that epidural 
dexmedetomidine 1µg/kg with bupivacaine 0.5% decreased the intra-operative 
anaesthetic requirements, prevented awareness during anaesthesia and 
improved  post-operative oxygenation and post-operative analgesia.  
7. Mausumi Neogi et al.,  24 (2010)  did a comparative study on 
paediatric patients undergoing elective inguinal herniotomy. They compared 
the efficacy of Clonidine 1 µg/kg and Dexmedetomidine  
1µg/kg as adjuvants to Ropivacaine for caudal analgesia.. They randomized 
the patients into 3 study groups, group R (Ropivacaine),  group C 
(Ropivacaine + Clonidine), group D (Ropivacaine + Dexmedetomidine) and 
observed that, the mean duration of analgesia was 6.32±0.46 hours in group 
R, 13.17±0.68 hours in group C and15.26±0.86  hours in group D. Duration of 
analgesia was significantly prolonged in both group C and group D in 
comparison to group R . They concluded that the addition of both Clonidine 
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and Dexmedetomidine with Ropivacaine administered caudally significantly 
increased the duration of analgesia.  
8. Gupta R Bogra et al., (2011)25 did a  study to compare Ropivacaine 
0.75% with Ropivacaine and Dexmedetomidine 5µg  by administering these 
drugs intrathecally in 60 patients. They concluded that the level of segmental 
regression to S2 and the duration of analgesia was significantly longer in 
Dexmedetomidine group also . Thus they also concluded that the addition of 
Dexmedetomidine prolonged the duration of analgesia. 
. 9. Sukhminder Jit Singh Bajwa et al., (2011)26  conducted  a  
randomized prospective  study  in 100 patients of ASA 1 and 2 between ages 
21 and 56 years who underwent lower limb orthopedic surgery. They did 
comparison of epidural 0.75% Ropivacaine 15ml+Dexmedetomidine 1µg/kg 
(RD) with epidural 0.75% Ropivacaine 15ml+Fentanyl 1µg/kg(RF). They 
observed that Dexmedetomidine added  to Ropivacaine produced  earlier 
onset of sensory analgesia at T10 (7.12±2.44 min) compared to Fentanyl 
(9.14±2.94 min).The complete onset of motor blockade (18.16±4.52 min) was 
earlier in  Dexmedetomidine compared to Fentanyl  (22.98±4.78 min). 
Postoperative analgesia was also prolonged in Dexmedetomidine (366.62± 
24.42) compared to Fentanyl (246.16±23.86) and consequently lower 
consumption of local anaesthetic in Dexmedetomidine group. 
Dexmedetomidine group  had better sedation scores. Side effects like nausea  
and vomiting  were significantly higher in Fentanyl group(26% and 
12%)while Dexmedetomidine group has higher incidence of dry mouth (14%) 
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.They concluded that Dexmedetomidine is a better alternative epidural 
adjuvant to Fentanyl. 
10. Vijay. G.Anand et al.27 (2011) conducted a study to compare the 
effects of caudal  Dexmedetomidine combined with Ropivacaine to provide 
post operative analgesia in children. The study was conducted in 60 children 
who had undergone lower abdominal surgeries. They were allocated into 2 
groups of 30 each. Group RD received 0.25% Ropivacaine 1 ml/kg with 
Dexmedetomidine 2µg/kg (made up to 0.5ml) and group R received 0.25% 
Ropivacaine 1ml/kg + 0.5 ml normal saline. Induction was done with 
50%N2Oand 8% Sevoflurane in O2 in spontaneous ventilation and then LMA 
was inserted .After that caudal block was performed and the study drug was 
given as mentioned above. The duration of post operative analgesia was 
recorded and median of 5.5 hrs in Group R  compared with 14.5 hours in 
Group RD.Group R patients achieved and statistically significant higher 
FLACC score compared to RD patients. The mean sedation score, emergence 
behavior score, mean emergence time was statistically highly significant in 
RD Group.The peri-operative hemodynamics were stable in both groups. To 
conclude caudal Dexmedetomidine (2µg/kg) with 0.25% Ropivacaine 2ml/kg 
for paediatric lower abdominal surgeries achieved significant post operative 
pain relief that resulted in a better quality of sleep and prolonged duration of 
arousable sedation. 
11. Essam Shafiqet al.,(2012)28 conducted, a prospective randomized 
study in 72 children between the age group 8 months to 8yrs for infra-
umbilical surgeries.  The patients were allocated into 3 groups  24 each. 
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Group A(0.25% Ropivacaine 1ml/kg), Group B (0.25% Ropivacaine with 
Fentanyl 1 μg/kg), Group C (0.25% Ropivacaine and Dexmedetomidine 2 
μg/kg). Patients were monitored for postoperative analgesia (FLACC score). 
Prolonged analgesia with less FLACC score(13.5hrs) in Group C ,compared to 
4.5hrs and 8.5hrs in Group A and group B respectively. 
12. Bhawna Rastogi et al 29 (2013) done a study  comparing the 
efficacy of epidural 0.75% Ropivacaine  with Fentanyl(RF) with 0.5% 
Bupivacaine with Fentanyl (BF)for hemiarthroplasty in high risk patients. 60 
patients of ASA 1&2 with no difference in their demographic profile were 
administered 15ml of either drug with 50µg of Fentanyl .Mean sensory level 
at T10 was achieved  faster in RF group . The onset of complete motor block 
was  also earlier in RF  group than BF(17.5±3.4 vs. 21.7±7.8). Intra-operative 
hemodynamic parameters showed significant differences. They concluded that 
0.75% Ropivacaine with Fentanyl as much better drug than Bupivacaine with 
fentanyl 
13. Ajay Kumar Anandan et al.,(2014)30 conducted a study 
comparing  Ropivacaine with  Dexmedetomidine (RD) with Ropivacaine (R) 
in 30 patients and concluded that the onset was earlier in RD (3.60min.) 
compared with R group (4.60 min.). and the  duration of analgesia was 
prolonged in RD (289min.) compared to R group (243 min). 
14. Manal M.Kamal et al., (2014)31 conducted a  prospective study by 
allocating randomly sixty patients undergoing abdominal surgery into group I 
- Levobupivacaine Morphine (LM) group and group II: Levobupivacaine 
Dexmedetomidine (LD) group. Group I patients received 20 ml of 0.5% 
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Levobupivacaine (150 mg) and Morphine 1 mg. Group II patients received 
20 ml of 0.5% Levobupivacaine and 1.5 μg/kg Dexmedetomidine. The onset, 
extent, duration of sensory and motor blocks, abdominal muscle relaxation 
and side effects were recorded. Time to reach motor block was shorter in the 
LM group than in  LD group. There were no significant difference between 
the time of total regression of sensory or motor block and abdominal muscle 
relaxation. Regarding side effects, more patients in the LM group suffered 
from pruritis and more patients suffered from dry mouth in the LD group. 
They concluded that Dexmedetomidine is a good alternative to Morphine as 
an adjuvant to Levobupivacaine in epidural anaesthesia in major abdominal 
surgeries. 
15 .MS Saravana babu et al., (2014)32 conducted a  prospective 
randomized study in 60 patients to evaluate the efficacy and clinical profile of 
Dexmedetomidine and Clonidine as an adjuvant to Ropivacaine,for epidural 
analgesia in spine surgeries by giving 20 ml of 0.2% Ropivacaine and 1 μg/kg 
of Dexmedetomidine (group RD) or 20 ml of 0.2% Ropivacaine and 2 μg/kg 
of Clonidine (group RC).18  
They observed that the addition of Dexmedetomidine to Ropivacaine as 
an adjuvant resulted in an earlier onset (7.33±1.76 min) of analgesia as 
compared to the addition of Clonidine (8.40±1.61 min). The duration of  
analgesia was also prolonged in Dexmedetomidine group (407.00±47.06 min) 
compared to Clonidine group (345.01±35.02). The need for IV rescue 
analgesics in both the groups was nil throughout the study period. The mean 
VAS score was higher in the Clonidine group at each time interval. They 
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concluded from the study that, the epidural route provided adequate analgesia 
in spine surgeries and RD Group had early onset, prolonged post operative 
analgesia and stable haemodynamics than RC Group. 
16. Sarabjit Kaur et al.,33 (2014) conducted a  prospective, 
randomized double-blind study in 100 patients undergoing lower limb 
surgeries by randomly into groups receiving 150 mg of 0.75% Ropivacaine 
(Group A)  and 150 mg of 0.75% Ropivacaine with Dexmedetomidine (1 
μg/kg) (Group B). Two groups were compared with hemodynamic changes, 
block characteristics which included time to onset of analgesia at T10, 
maximum sensory analgesic level and time to the first dose of rescue 
analgesia. Significant difference was observed in relation to the duration of 
sensory block (375.20 ± 15.97 min. in Group A and 535.18 ± 19.85 min. in 
Group B, and consequently low doses of rescue analgesia in Group B (1.44 ± 
0.501) as compared to Group A (2.56 ± 0.67). They concluded that Epidural 
Dexmedetomidine as an adjuvant to Ropivacaine associated with prolonged 
sensory and motor block, hemodynamic stability, prolonged postoperative 
analgesia and reduced demand for rescue analgesics when compared to plain 
Ropivacaine. 
17) Turner et al34, showed in an observational study that epidural 
catheters placed intraoperatively by the surgeon followed by infusion of local 
anesthetics with or without opioids were capable of providing good analgesia 
after posterior spinal fusion. 
18) Ravi prakash , B. B. Kushwaha, Shashibhushan, V.K.Bhatia, 
Girish Chandra and B.P.Singh et al35 did a comparative study of 
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Bupivacaine 0.25% alone and with Fentanyl or Dexmedetomidine for 
percutaneous nephrolithotomy (pcnl) under epidural anaesthesia. The study 
was conducted on 75 patients who were randomly allocated in three groups, 
Group A (n=25): patient receiving only 20 ml epidural 0.25% Bupivacaine. 
Group B (n=25): patient receiving 20 ml epidural0.25% Bupivacaine along 
with Fentanyl (1mcg/kg) and Group C (n=25): patient receiving 20 ml 
epidural 0.25% Bupivacaine along with Dexmedetomidine (1mcg/kg).They 
observed that addition of Fentanyl and Dexmedetomidine prolongs the 
duration of analgesia. Dexmedetomidine was more effective in this respect. 
Time for 2 segment regression was 86.52 ± 9.07minutes for Group A,  120.00 
± 5.95 minutes for . Group B and 135.40 ± 9.57 minutes for Group C. 
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AIM AND OBJECTIVES 
Comparison of post operative  analgesia using Epidural Ropivacaine 
and Dexmedetomidine with Ropivacaine and Fentanyl,  in patients undergoing 
elective spine surgeries with respect to:  
1) Onset of analgesia 
2) Time of peak onset of analgesia 
3) The duration of  analgesia 
4) The need of rescue analgesics  
5) Post-operative haemodynamics   
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MATERIALS AND METHODS 
The study was conducted at the Institute of Anaesthesiology and 
Critical Care, Rajiv Gandhi Government General Hospital, Chennai between  
2014- 2015. Ethical committee approval was obtained from the institution. 60 
patients were randomly selected based on inclusion criteria and after 
obtaining written informed consent , patients were allocated into two equal 
groups.  
STUDY DESIGN 
Prospective, randomized, double blinded study 
STUDY PLACE 
Institute of Anaesthesiology and Critical Care, Rajiv Gandhi 
Government General Hospital, Chennai.   
STUDY PERIOD 
2014- 2015. 
STUDY POPULATION 
60 Patients were selected and allocated in two groups 
ETHICAL CONSIDERATION 
Approval was obtained from the Institutional ethics committee before 
the commencement of the study. Informed consent was obtained from all the 
patients participated in this study. All patients satisfying the inclusion criteria 
were included. Patients were interviewed by structured questionnaire. 
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Statistical analysis: Descriptive statistics was done for all data and 
suitable statistical tests of comparison were done. Continuous variables were 
analyzed with the unpaired t test and categorical variables were analyzed with 
the Chi-Square Test and Fisher Exact Test. Statistical significance was taken 
as P < 0.05. The data was analyzed using EpiInfo software (7.1.0.6 version; 
Center for disease control, USA) and Microsoft Excel 2010. 
INCLUSION CRITERIA 
 Age   : 20-65 years  
 ASA   : I & II 
 Elective Surgeries 
 Who have given valid informed consent.  
 Lower thoracic  below T8 and lumbosacral spine surgeries 
EXCLUSION CRITERIA 
 ASA III & IV 
 Patients with heart block, Bradyarrthymia and Left ventricular 
failure 
 Hematological  disease, Bleeding or coagulation abnormalities 
 Psychiatric diseases, TB spine and any  other permanent 
neurological  disorders 
PREOPERATIVE PREPARATION 
Patients, age, body weight and baseline vital parameters were recorded. 
History regarding previous anaesthesia, surgery and other significant  co 
morbid illness, medications and allergy was also recorded. Complete physical 
examination and airway assessment were done. 
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In the preoperative period all patients were explained about the 
benefits of Epidural anaesthesia and 10-point visual analogue scale and  
informed consent was obtained from the study group patients. 
PREMEDICATION 
All patients were premedicated with tablets Ondansetron 4mg and 
Ranitidine 150 mg at 6 am on the day of surgery. They also received tab. 
Diazepam 0.2mg/kg orally night before surgery.  
MATERIALS USED  
 18 Gauge Tuohy needle, 20 Gauge Epidural catheter  
 Drugs–inj. Ropivacaine, inj. Dexmedetomidine, inj. Fentanyl , 
emergency drugs and normal saline 
 Monitors – Electro Cardio Gram, Noninvasive blood pressure monitor, 
pulseoximetry (spo2). 
 
 
 
 
 
MONITORING AND INTRAVENOUS ACCESS  
Continuous ECG and SpO₂, Noninvasive blood pressure monitoring 
done. Intravenous access was done using 16 or 18 Gauge venflon and 
crystalloid was started. 
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PROCEDURE 
In the operation theatre the monitors were connected and  baseline 
heart rate, SpO₂, blood pressure were recorded. All cases were  premedicated 
with  Inj.Glycopyrollate 0.05mg/kg and with Inj.fentanyl 2µg/kg ,and  
induced with Thiopentone 5mg/kg. Intubation was done with Suxamethonium 
1mg/kg and maintained by Atracurium 0.5mg/kg and Oxygen and Nitrous 
oxide in the ratio of 1:3.with volatile anaesthetics. After completion of the 
surgical procedure and before closure of the wound, 20 gauge epidural 
catheter was placed under direct vision in the epidural space by separate skin 
puncture  about 2.5 cm away from the main surgical incision  with 16 gauge 
Tuohy needle. The catheter was positioned up to 7  to 10 cm from skin entry 
directed upwards in the epidural space under direct vision. The catheter was 
secured in place on the back of the patient using an adhesive tape. After 
closing and dressing the surgical wound  the patient was extubated after 
adequate reversal. Patients were shifted to post-anaesthetic care unit and 
monitored. Once the patient was noted to have pain (visual analogue scale 
(VAS) of>4), the study started. A test dose of 3 ml Lignocaine with 
Adrenaline (1:200,000) was injected and the patients were randomly allocated 
to one of the following two groups in a double-blinded method:  
Group-1: (Ropivacaine + Dexmedetomidine (RD) (n=30); Ropivacaine   
0.2% 15 ml plus Dexmedetomidine 1 mcg/kg.  
Group-2: (Ropivacaine + Fentanyl (RF) (n=30); Ropivacaine 0.2% 
15ml plus Fentanyl 1 mcg/kg.  
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Epidural catheter placement through seperate skin puncture from the 
main surgical incision with Tuohy needle. 
 
After administering the drug, the following parameters were recorded 
by the independent observer. 
1) The pain score using Visual Analogue Scale (VAS) every 2 min for 30 
min and then every 30 min until the need for next epidural top up.  
2) Onset of analgesia (fall of VAS<4 after epidural drug). 
3) Peak level of analgesia (achieving VAS score 0).  
4) Duration of analgesia (starting from epidural drug administration to 
once the patient asks for additional rescue analgesia with VAS>4).          
5) Monitoring of vital parameters such as NIBP,  pulse rate,  respiratory 
rate every 30 min. 
6) Side-effects such as nausea, vomiting, respiratory depression, deep 
sedation (Ramsay sedation scale>3), shivering ,dry mouth , bradycardia  
and hypotension and  requirement for IV rescue analgesics (injection 
Diclofenac).  
7) Once the patient asked for additional epidural analgesia (VAS>4) for 
pain relief during the observation period, the study ended and the 
above mentioned parameters were noted. 
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RECORDING OF ADVERSE EFFECTS 
Adverse events like hypotension, bradycardia, nausea, vomiting, dry 
mouth were noted. Hypotension (defined as systolic arterial pressure falling 
more than 20% from the pre-operative level) was treated with injection 
ephedrine 3-6 mg IV bolus and heart rate less than 50 beats/min was treated 
with 0.01 mg/kg of injection atropine. Post-operative maintenance IV fluids 
were given as per body weight. Nausea and vomiting were treated with 0.1 
mg/kg of IV Ondansetron.  
ASSESSMENT  OF PAIN  USING  VISUAL  ANALOG  SCORE (VAS) 
 
 
 
 
 
 
The pain was assessed using visual analogue scale rating from 0 to 10 
during intra operative period 
RAMSAY SEDATION SCORE 
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OBSERVATION AND RESULTS 
Descriptive statistics was done for all data and suitable statistical tests 
of comparison were done. Continuous variables were analyzed with the 
unpaired t test and categorical variables were analyzed with the Chi-Square 
Test and Fisher Exact Test. Statistical significance was taken as P < 0.05. The 
data was analyzed using EpiInfo software (7.1.0.6 version; Center for disease 
control, USA) and Microsoft Excel 2010. 
Table 1. Group distribution (n=60) 
Groups Group Names Intervention Used Procedure 
RD 
Ropivacaine + 
Dexmedetomidine. 
Post- operative epidural 
block with Ropivacaine 
and Dexmedetomidine. 
In post-operative 
patients who are 
undergoing 
elective spine 
surgeries RF 
Ropivacaine +  
Fentanyl. 
Post- operative epidural 
block with Ropivacaine 
and  Fentanyl. 
SAMPLE SIZE CALCULATION 
Sample size was determined  based on, the comparative study in the 
post-operative spine surgeries: Epidural Ropivacaine with Dexmedetomidine 
and Ropivacaine with Fentanyl for post-operative analgesia, Authored by MS 
Saravana Babu et al published in Indian Journal of Anaesthesia | Vol. 57 | 
Issue 4 | Jul-Aug 2013. 
In this study the duration of analgesia has a mean difference of 62 
minutes which is highly significant at 0.001.  
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DESCRIPTION 
 The confidence level is estimated at 95% 
 With a z value of 1.96 
 The confidence interval or margin of error is estimated at +/-12 
 Assuming that the sample will have the specified attribute p% =62 and 
q%=38 
n = p% x q% x [z/e%] ² 
n=62 x 38 x [1.96/15]² 
n= 40.23 
Therefore 40 is the minimum sample size required for the study 
In our study we have taken 60 as the sample size. 
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Table-2: Age distribution (n=30 in Group RD and n=30 in  
Group RF) 
Age Distribution RD Group % RF Group % 
≤ 30 Years 9 30.00 7 23.33 
31-40 Years 12 40.00 9 30.00 
41-50 Years 7 23.33 9 30.00 
51-60 Years 2 6.67 4 13.33 
> 60 Years 0 0.00 1 3.33 
Total 30 100 30 100 
 
Age Distribution RD Group RF Group 
N 30 30 
Mean 36.10 39.50 
SD 10.83 11.02 
P value 
Unaired t test 
0.233028 
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Majority of the Ropivacaine + Dexmedetomidine group patients 
belonged to the 31-40 years age group (n=12, 40%) with a mean age of 36.10 
years. In the Ropivacaine +  Fentanyl group patients, majority belonged to the 
same age group as Ropivacaine + Dexmedetomidine group (n=9, 30%) with a 
mean age of 39.50 years. The association between the intervention groups and 
age distribution is considered to be not statistically significant since p > 0.05 
as per unpaired t test. 
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Table 3. Gender distribution 
Gender Distribution RD Group % RF Group % 
Male 18 60.00 16 53.33 
Female 12 40.00 14 46.67 
Total 30 100 30 100 
P value 
Fishers Exact Test 
0.7948 
 
 
Majority of the Ropivacaine + Dexmedetomidine group patients 
belonged to the male gender group (n=16, 60%). In the Ropivacaine +  
Fentanyl group patients, majority belonged to the male gender group (n=16, 
53.33%). The association between the intervention groups and gender 
distribution is considered to be not statistically significant since p > 0.05 as 
per fishers exact test. 
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Table4.Weight distribution 
Weight Distribution RD Group % RF Group % 
≤ 50 kgs 1 3.33 0 0.00 
51-60 kgs 5 16.67 9 30.00 
61-70 kgs 21 70.00 17 56.67 
71-80kgs 3 10.00 4 13.33 
Total 30 100 30 100 
 
Weight Distribution RD Group RF Group 
N 30 30 
Mean 66.23 65.47 
SD 5.77 6.41 
P value 
Unaired t test 
0.6282 
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Majority of the Ropivacaine + Dexmedetomidine group patients 
belonged to the 61-70 kgs weight group (n=21, 70%) with a mean weight of 
66.23 kgs. In the Ropivacaine +  Fentanyl group patients, majority belonged 
to the same weight group as Ropivacaine + Dexmedetomidine group (n=17, 
56.67%) with a mean weight of 65.47 years. The association between the 
intervention groups and weight distribution is considered to be not 
statistically significant since p > 0.05 as per unpaired t test. 
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Table 5. ASA physical status classification 
ASA Physical Status Classification RD Group % RF Group % 
ASA I 23 76.67 20 66.67 
ASA II 7 23.33 10 33.33 
Total 30 100 30 100 
P value 
Fishers Exact Test 
0.5675 
 
Majority of the Ropivacaine + Dexmedetomidine group patients 
belonged to the ASA classification I group (n=23, 76.67%). In the 
Ropivacaine +  Fentanyl group patients, majority belonged to the ASA 
classification I group (n=20, 66.67%). The association between the 
intervention groups and ASA physical status classification is considered to be 
not statistically significant since p > 0.05 as per fishers exact test. 
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Table6.Time of administration of drug after surgery 
Time of Administration of  
drug  After Surgery RD Group % RF Group % 
≤ 10 Minutes 1 3.33 0 0.00 
11-15 Minutes 21 70.00 25 83.33 
16-20 Minutes 8 26.67 5 16.67 
Total 30 100 30 100 
 
Time of Administration After Surgery RD Group RF Group 
N 30 30 
Mean 16.07 14.97 
SD 2.63 2.04 
P value 
Unaired t test 
0.0756 
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Majority of the Ropivacaine + Dexmedetomidine group patients 
belonged to the 11-15 minutes after surgery drug administration time group 
(n=21, 70%) with a mean time of administration after surgery of 16.07 
minutes. In the Ropivacaine +  Fentanyl group patients, majority belonged to 
the same class interval as Ropivacaine + Dexmedetomidine group (n=25, 
83.33%) with a mean time of administration after surgery of 14.97 minutes. 
The association between the intervention groups and time of administration 
after surgery distribution is considered to be not statistically significant since 
p > 0.05 as per unpaired t test. 
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Table 7. Drug Onset Time 
Drug Onset Time RD Group % RF Group % 
4 Minutes 6 20.00 1 3.33 
6 Minutes 20 66.67 12 40.00 
8 Minutes 3 10.00 8 26.67 
10 Minutes 1 3.33 9 30.00 
Total 30 100 30 100 
 
Drug Onset Time RD Group RF Group 
N 30 30 
Mean 5.93 7.67 
SD 1.34 1.83 
P value Unaired t test 0.0001 
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By conventional criteria the association between the intervention 
groups and drug onset  time is considered to be statistically significant since p 
< 0.05 as per unpaired t test. In simple terms, Most of the Ropivacaine + 
Dexmedetomidine group patients belong to 6 minutes drug onset time class 
interval (n=20, 66.67%) with a mean drug onset time of 5.93 minutes. 
Similarly in the Ropivacaine +  Fentanyl group majority of the patients 
belonged to the 6 minutes drug onset time class interval (n=12, 40%) with a 
mean drug onset time of 7.67 minutes.  This indicates that there is a true 
difference among intervention groups and the difference is significant with a 
p-value of 0.0001.  
 The mean drug onset time was meaningfully less in Ropivacaine + 
Dexmedetomidine intervention group compared to Ropivacaine +  Fentanyl  
intervention group by a mean time of 1.73 minutes. This significant difference 
of 23% reduction in mean drug onset time among patients belonging to 
Ropivacaine + Dexmedetomidine intervention group compared to Ropivacaine 
+  Fentanyl  intervention group is true and has not occurred by chance. 
 In this study we can safely conclude that Post- operative epidural 
block with Ropivacaine + Dexmedetomidine results in significantly lowered 
drug onset time compared to Post- operative epidural block with Ropivacaine 
+  Fentanyl  when used in post-operative patients who underwent elective 
spine surgeries 
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Table 8. Drug Peak Time 
Drug Peak Time RD Group % RF Group % 
≤ 10 Minutes 16 53.33 5 16.67 
11-15 Minutes 11 36.67 20 66.67 
16-20 Minutes 3 10.00 5 16.67 
Total 30 100 30 100 
 
Drug Peak Time RD Group RF Group 
N 30 30 
Mean 12.07 13.13 
SD 3.08 2.27 
P value 
Unaired t test 
0.1330 
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Majority of the Ropivacaine + Dexmedetomidine group patients 
belonged to the ≤ 10 minutes drug peak time class interval (n=16, 53.33%) 
with a mean drug peak  time of 12.07 seconds. In the Ropivacaine +  Fentanyl 
group patients, majority belonged to 11-15 minutes drug peak time class 
interval (n=20, 66.67%) with a mean drug peak time of 13.13 seconds. The 
association between the intervention groups and drug peak time distribution is 
considered to be not statistically significant since p > 0.05 as per unpaired t 
test. 
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Table 9. Drug Duration Time 
Drug Duration Time RD Group % RF Group % 
≤ 4 Hours 3 10.00 6 20.00 
5-6 Hours 22 73.33 24 80.00 
7-8 Hours 5 16.67 0 0.00 
Total 30 100 30 100 
 
Drug Duration Time RD Group RF Group 
N 30 30 
Mean 5.83 4.97 
SD 0.99 0.72 
P value 
Unaired t test 
0.0003 
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Majority of the Ropivacaine + Dexmedetomidine(RD) group patients 
belonged to the 5-6 hours drug duration time class interval (n=22, 73.33%) with a 
mean drug duration time of 5.83 hours. In the Ropivacaine +  Fentanyl(RF) group 
patients, majority belonged to the same class interval as RD group (n=24, 80%) with a 
mean drug duration time of 4.97 hours. The association between the intervention 
groups and drug duration time distribution is considered to be  statistically significant 
since p < 0.05 as per unpaired t test. 
By conventional criteria the association between the intervention groups and 
drug duration  time is considered to be statistically significant since p < 0.05 as per 
unpaired t test. In simple terms, Majority of the RD intervention group patients 
belonged to the 5-6 hours drug duration time class interval (n=22, 73.33%) with a 
mean drug duration time of 5.83 hours. In the RF group patients, majority belonged to 
the same class interval as RD group (n=24, 80%) with a mean drug duration time of 
4.97 hours.  This indicates that there is a true difference among intervention groups 
and the difference is significant with a p-value of 0.0003.   
The mean drug duration  of analgesia was meaningfully more in Ropivacaine 
+ Dexmedetomidine intervention group compared to Ropivacaine +  Fentanyl  
intervention group by a mean time of 52.20 minutes. This significant difference of 
1.17 times increase  in mean drug onset time among patients belonging to 
Ropivacaine + Dexmedetomidine intervention group compared to Ropivacaine +  
Fentanyl  intervention group is true and has not occurred by chance. In this study we 
can safely conclude that  Ropivacaine + Dexmedetomidine results in significantly 
longer duration of analgesia compared to  Ropivacaine +  Fentanyl  when used in 
post-operative patients who underwent elective spine surgeries. 
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Table 10. Heart Rate 
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RD 
Group 
N 30 30 30 30 30 30 30 30 30 30 30 30 30 
Mean 77.33 90.60 83.57 76.80 71.97 69.03 67.83 68.43 71.27 76.20 77.73 82.17 83.17 
SD 5.96 7.56 6.65 6.25 6.97 8.05 8.36 8.37 8.98 9.46 6.80 7.46 6.66 
RF 
Group 
N 30 30 30 30 30 30 30 30 30 30 30 30 30 
Mean 76.80 91.30 82.47 76.43 75.23 72.37 73.93 76.43 83.10 83.03 74.80 85.70 81.87 
SD 6.93 6.78 5.14 7.14 6.82 6.40 6.79 7.52 9.56 8.80 9.98 9.72 8.34 
 P value  
Unpaired  
t test 
0.7505 0.7073 0.4768 0.8332 0.0716 0.0813 0.0030 0.0003 0.0000 0.0053 0.1893 0.1201 0.5076 
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By conventional criteria the association between the intervention 
groups and heart rate is considered to be statistically significant between 3-6 
hours since p < 0.05 as per unpaired t test. In simple terms, in patients 
belonging to Ropivacaine + Dexmedetomidine intervention group, the heart 
rate  is decreased to an average of  70.93 beat per minute in comparison with 
patients belonging to Ropivacaine +  Fentanyl  intervention group in whom 
the heart rate is an average of  79.13 beat per minute. This indicates that there 
is a true difference among intervention groups and the difference is 
significant with a p-value of < 0.05 according to unpaired t-test. 
 The heart rate was meaningfully less in Ropivacaine + 
Dexmedetomidine intervention group compared to Ropivacaine +  Fentanyl  
intervention group by a mean difference of 8.19 beat per minute . This 
significant difference of 10% reduction in heart rate in Ropivacaine + 
Dexmedetomidine intervention group compared to Ropivacaine +  Fentanyl  
intervention group is true and has not occurred by chance. 
 In this study we can safely conclude that Post- operative epidural 
block with Ropivacaine + Dexmedetomidine results in significantly lower 
heart rate compared to Post- operative epidural block with Ropivacaine +  
Fentanyl  when used in post-operative patients who underwent elective spine 
surgeries. 
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Table 11. Systolic Blood Pressure 
 
Sy
st
ol
ic
 B
lo
od
 
Pr
es
su
re
 
SB
P-
B
L
 
SB
P-
0 
SB
P-
15
 M
in
s 
SB
P-
30
 M
in
s 
SB
P-
1 
hr
 
SB
P-
2 
 h
r 
SB
P-
3 
 h
r 
SB
P-
4 
 h
r 
SB
P-
5 
 h
r 
SB
P-
6 
 h
r 
SB
P-
8 
 h
r 
SB
P-
10
  h
r 
SB
P-
12
  h
r 
RD 
Group 
N 30 30 30 30 30 30 30 30 30 30 30 30 30 
Mean 127.07 129.13 120.40 115.73 111.83 109.80 108.80 109.73 114.43 118.30 124.33 125.03 120.40 
SD 11.30 8.08 7.05 7.42 7.07 10.08 8.69 4.16 9.50 11.67 8.58 8.91 7.36 
RF 
Group 
N 30 30 30 30 30 30 30 30 30 30 30 30 30 
Mean 130.00 129.90 119.33 116.27 113.80 112.67 111.70 112.07 114.17 123.33 123.40 122.67 120.80 
SD 9.39 8.20 7.01 6.10 5.02 5.34 5.22 5.13 7.09 10.36 9.93 9.18 9.23 
 P value  
Unpaired  
t test 
0.2788 0.7166 0.5593 0.7622 0.2195 0.1756 0.1238 0.0581 0.9024 0.0826 0.6983 0.3150 0.8534 
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Most of the Ropivacaine + Dexmedetomidine intervention group patients had mean SBP ranging from 127. 07 mm Hg at 
baseline to 120.40 mm Hg at the end of 12 hours. Similarly the Ropivacaine +  Fentanyl  intervention  group patients had mean  
SBP ranging from 130.00 mm Hg at baseline to 120.80 mm Hg at the end of 12 hours. By conventional criteria th e association 
between the intervention groups and systolic blood pressure is considered to be not statistically significant since p > 0.05 as per 
unpaired t test. 
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Table 12. Diastolic Blood Pressure 
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Mean 77.93 84.80 76.47 74.73 72.77 71.60 68.53 72.93 73.60 78.60 83.10 79.87 79.03 
SD 6.96 6.23 4.78 3.50 6.33 7.97 14.00 3.00 13.83 8.31 7.48 5.04 5.97 
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Mean 79.60 87.47 77.93 76.13 74.50 73.93 70.70 72.60 73.80 79.73 82.97 83.13 79.10 
SD 7.30 6.64 5.95 4.73 5.08 3.38 12.16 3.94 5.14 9.12 7.83 6.19 5.38 
P value 
Unpaired  
t test 
0.3691 0.1141 0.2971 0.1979 0.2474 0.1480 0.5247 0.7138 0.9412 0.6168 0.9465 0.2891 0.9639 
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Most of the Ropivacaine + Dexmedetomidine intervention group patients had mean DBP ranging from 77.93 mm Hg at 
baseline to 79.03 mm Hg at the end of 12 hours. Similarly the Ropivacaine +  Fentanyl  intervention group patients had mean  
DBP ranging from 79.60 mm Hg at baseline to 79.10 mm Hg at  the end of 12 hours. By conventional criteria the association 
between the intervention groups and diastolic blood pressure is considered to be not statistically s ignificant since p > 0.05 as 
per unpaired t test. 
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Table 13. Mean Arterial Pressure  
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N 30 30 30 30 30 30 30 30 30 30 30 30 30 
Mean 77.33 90.60 83.57 76.80 71.97 69.03 67.83 68.43 71.27 76.20 77.73 82.17 83.17 
SD 5.96 7.56 6.65 6.25 6.97 8.05 8.36 8.37 8.98 9.46 6.80 7.46 6.66 
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N 30 30 30 30 30 30 30 30 30 30 30 30 30 
Mean 76.80 91.30 82.47 76.43 75.23 72.37 73.93 76.43 83.10 83.03 74.80 85.70 81.87 
SD 6.93 6.78 5.14 7.14 6.82 6.40 6.79 7.52 9.56 8.80 9.98 9.72 8.34 
 P value  
Unpaired  
t test 
0.7505 0.7073 0.4768 0.8332 0.0716 0.0813 0.0030 0.0003 0.0000 0.0053 0.1893 0.1201 0.5076 
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Most of the Ropivacaine + Dexmedetomidine intervention group patients had mean MAP ranging from 94.3 7 mm Hg at 
baseline to 92.43 mm Hg at the end of 12 hours. Similarly the Ropivacaine +  Fentanyl  intervention group patients had mean  
MAP ranging from 96.47 mm Hg at baseline to 92.93 mm Hg at the end of 12 hours. By conventional crit eria the association 
between the intervention groups and mean arterial pressure is considered to be not statistically significant since p  > 0.05 as per 
unpaired t test. 
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Table 14. Visual Analogue Scale 
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Mean 4.33 4.13 3.93 2.67 2.07 1.73 1.07 0.33 0.07 0.07 0.00 0.00 
SD 0.92 0.51 0.37 0.96 0.37 0.69 1.01 0.76 0.37 0.37 0.00 0.00 
P value  
Unpaired  
t test 
0.3036 1.0000 0.0472 0.0250 0.0309 0.0008 0.0355 0.4562 0.3097 0.3097 > 0.999 > 0.999 
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SD 0.00 0.00 0.37 0.81 1.48 1.26 0.81 0.64 0.64 0.86 0.96 
P value 
Unpaired t test > 0.999 > 0.999 0.3256 0.1841 0.0494 0.0000 0.2978 0.1611 0.0326 0.0268 0.0028 
 72 
 
 
 73
By conventional criteria the association between the intervention 
groups and VAS score is considered to be statistically significant between 4-
12 minutes, 5-6 hours and 9-12 hours since p < 0.05 as per unpaired t test. In 
simple terms, in patients belonging to Ropivacaine + Dexmedetomidine 
intervention group, the VAS score is decreased to an average of  1.79  in 
comparison with patients belonging to Ropivacaine +  Fentanyl  intervention 
group in whom the heart rate is an average of  2.31. This indicates that there 
is a true difference among intervention groups and the difference is 
significant with a p-value of < 0.05 according to unpaired t-test.  
The VAS score was meaningfully less in Ropivacaine + 
Dexmedetomidine intervention group compared to Ropivacaine +  Fentanyl  
intervention group by a mean difference of 0.52. This significant difference of 
23% reduction in VAS score in Ropivacaine + Dexmedetomidine intervention 
group compared to Ropivacaine +  Fentanyl  intervention group is true and 
has not occurred by chance. 
 In this study we can safely conclude that Post- operative epidural 
block with Ropivacaine + Dexmedetomidine results in significantly lowered 
Visual Analogue Scale score compared to Post- operative epidural block with 
Ropivacaine +  Fentanyl  when used in post-operative patients who are 
underwent elective spine surgeries. 
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Table 18. Rescue Analgesic Requirement 
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1 hr 0 0.00 0 0.00 >0.9999 
2 hr 0 0.00 0 0.00 >0.9999 
3 hr 0 0.00 0 0.00 >0.9999 
4 hr 0 0.00 1 1.96 >0.9999 
5 hr 3 7.89 5 9.80 0.7065 
6 hr 7 18.42 18 35.29 0.0082 
7 hr 15 39.47 6 11.76 0.2921 
8 hr 3 7.89 0 0.00 0.2373 
9 hr 2 5.26 2 3.92 1.0000 
10 hr 5 13.16 8 15.69 0.5321 
12 hr 3 7.89 11 21.57 0.0303 
Total 38 100.00 51 88  
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By conventional criteria the association between the intervention groups and 
rescue analgesic requirement is considered to be statistically significant at 6th, 7th and 
12th hour since p < 0.05 as per fishers exact test. In simple terms, the rescue analgesic 
requirement at 6th hour was less in  patients belonging to Ropivacaine + 
Dexmedetomidine intervention group(n=7, 18.42%) in comparison with patients 
belonging to Ropivacaine +  Fentanyl  intervention group (n=18, 35.29%) This 
indicates that there is a true difference among intervention groups and the difference is 
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significant with a p-value of 0.0082. The rescue analgesic requirement was meaningfully less 
in Ropivacaine + Dexmedetomidine intervention group at 6th hour compared to Ropivacaine +  
Fentanyl  intervention group by a difference of 16.87 percentage points. This significant 
difference of 1.92 times increase  in the rescue analgesic requirement in Ropivacaine +  
Fentanyl intervention group compared to  Ropivacaine + Dexmedetomidine intervention 
group is true and has not occurred by chance. 
Similarly the rescue analgesic requirement at 12 th hour was less in  patients 
belonging to Ropivacaine + Dexmedetomidine intervention group (n=3, 7.89%) in 
comparison with patients belonging to Ropivacaine +  Fentanyl  intervention group 
(n=11, 21.57%). This indicates that there is a true difference among intervention 
groups and the difference is significant with a p-value of 0.0303. The rescue 
analgesic requirement was meaningfully less in Ropivacaine + Dexmedetomidine 
intervention group at 12 th hour compared to Ropivacaine +  Fentanyl  intervention 
group by a difference of 13.67 percentage points. This significant difference of 2.73 
times increase  in the rescue analgesic requirement in Ropivacaine +  Fentanyl 
intervention group compared to  Ropivacaine + Dexmedetomidine intervention 
group is true and has not occurred by chance.  
 In this study we can safely conclude that Post- operative epidural block with 
Ropivacaine + Dexmedetomidine results in significantly lower rescue analgesic 
requirement compared to Post- operative epidural block with Ropivacaine +  
Fentanyl  when used in post-operative patients who are underwent elective spine 
surgeries. 
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Table 16. Ramsay Sedation Scale 
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Mean 1.27 2.70 2.00 2.47 2.77 2.73 2.60 2.10 1.87 1.43 1.77 1.80 
SD 0.45 3.83 0.00 0.51 0.43 0.45 0.50 0.48 0.35 0.50 0.43 0.61 
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 N 30 30 30 30 30 30 30 30 30 30 30 29 
Mean 1.13 2.07 2.03 2.20 2.27 2.03 2.10 2.13 1.80 1.80 1.67 1.76 
SD 0.35 0.25 0.18 0.41 0.45 0.32 0.31 0.43 0.48 0.41 0.55 0.44 
 P value  
Unpaired  
t test 
0.2034 0.3740 0.3256 0.0287 0.0000 0.0000 0.0000 0.7791 0.5421 0.0030 0.4344 0.7649 
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By conventional criteria the association between the intervention 
groups and RSS score is considered to be statistically significant between 1-4 
hours and 8th hour since p < 0.05 as per unpaired t test. In simple terms, in 
patients belonging to Ropivacaine + Dexmedetomidine intervention group, the 
RSS score is increased to an average of  2.40 in comparison with patients 
belonging to Ropivacaine +  Fentanyl  intervention group in whom the RSS 
score is an average of  2.08. This indicates that there is a true difference 
among intervention groups and the difference is significant with a p-value of 
< 0.05 according to unpaired t-test. The RSS score was meaningfully more in 
Ropivacaine + Dexmedetomidine intervention group compared to Ropivacaine 
+  Fentanyl  intervention group by a mean difference of 0.32. This significant 
difference of 1.15 times increase  in RSS score in Ropivacaine + 
Dexmedetomidine intervention group compared to Ropivacaine +  Fentanyl  
intervention group is true and has not occurred by chance. 
 In this study we can safely conclude that Post- operative epidural 
block with Ropivacaine + Dexmedetomidine results in significantly higher 
Ramsay Sedation Scale score compared to Post- operative epidural block with 
Ropivacaine +  Fentanyl  when used in post-operative patients who  
underwent elective spine surgeries. 
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Table 17.Complications 
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Post-Operative Nausea vomiting 1 7.14 3 50.00 0.6120 
Hypotension 4 28.57 0 0.00 0.0562 
Bradycardia 4 28.57 0 0.00 0.0562 
Respiratory Depression 0 0.00 1 16.67 >0.9999 
Pruritus 0 0.00 2 33.33 0.4915 
Delirium 0 0.00 0 0.00 >0.9999 
Dry Mouth 5 35.71 0 0.00 0.0522 
Total 14 100 6 100  
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Most of the Ropivacaine + Dexmedetomidine intervention group 
patients had dry mouth as the presenting complication ( n=5. 35.71%) . 
Similarly the Ropivacaine +  Fentanyl  intervention group patients had 
pruritis as the presenting complication ( n=2, 33.33%). By conventional 
criteria the association between the intervention groups and complications is 
considered to be not statistically significant since p > 0.05 as per fishers exact 
test. 
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DISCUSSION 
Patients undergoing spinal surgeries experience severe pain in the 
postoperative period, which may increase the morbidity , incidence of 
complications and prolong postoperative rehabilitation. Postoperative pain 
therapy mainly  consists of administration of oral or intravenous opioids in 
combination with non steroidal anti-inflammatory drugs, but it often results in 
insufficient pain control and side effects such as respiratory depression, 
nausea, and vomiting 
. Epidural anesthesia and analgesia have been shown to be superior to 
intravenous analgesia with respect to  quality of pain relief, incidence of side 
effects,  pulmonary, cardiac, and gastrointestinal dysfunction. Turner et 
al.(34), showed in an observational study that epidural catheters placed 
intraoperatively by the surgeon followed by infusion of local anesthetics with 
or without opioids were capable of providing good analgesia after posterior 
spinal fusion. Even when the epidural space was disrupted during surgery, 
local anesthetic that leaks out from epidural space acts  like wound 
infiltration. 
A good cooperation and communication is needed with the respective 
surgeon , who places the epidural catheter  directly into the surgical field. It is 
easy to understand that surgeons are afraid of development of any kind of 
infection of the wound or the epidural space, especially after spine surgery, 
because even small hematomas are an excellent medium for bacteria. At first 
glance, a catheter directly placed in this area does not gain acceptance in the 
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eyes of the surgeons, irrespective of the applied medication. Apart from 
dislodgement, the placement of an epidural catheter into a recently operated 
area in the vertebral column with epidural application of local anesthetics 
may include the problem of unpredictable absorption of the drug and motor 
blockade.  
An ideal adjuvant should provide a longer duration of analgesia and 
better hemodynamic stability. There is a reduced requirement of analgesics 
with the use of  an epidural adjuvant due to the property of augmentation of 
the local anaesthetic effects, thereby prolonging the duration of analgesia.  
To avoid neuraxial  opioid induced adverse effects such as respiratory 
depression, nausea, vomiting, urinary retention and  pruritus, α-2 agonists are 
being used as an alternative epidural adjuvants. Introduction of this newer 
agent Dexmedetomidine has increased the  scope of α-2 agonists usage in 
neuraxial blockade. Rapid onset of local anaesthetic action, longer period of 
analgesia and better cardiovascular parameters have widened the scope of 
usage of Dexmedetomidine epidurally. 
In our prospective  randomized control  study, we  compared the 
analgesic efficacy of Fentanyl 1µg/kg  and Dexmedetomidine 1µg/kg which  
were  added to 15 ml  0.2%  Ropivacaine , by giving these drugs through an 
epidural catheter  in 60 patients underwent elective spine surgeries. The 
efficacy of Dexmedetomidine verses fentanyl as an adjuvant in epidural 
analgesia   was studied. The patients in both the groups with respect to age, 
weight, ASA Physical status did not show a statistically significant 
difference. 
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ONSET OF ANALGESIA 
Sukhminder jit singh bajwa et al (19).,did a comparative study in 100 
patients who underwent elective lower limb  orthopaedic surgeries under 
lumbar epidural with Dexmedetomidine 1µg/kg and Fentanyl 1µg/kg added to 
Ropivacaine 0.75% as the study drug. In that study the onset time to reachT10 
sensory level, was significantly shorter in group RD (7.12 ±2.44mon.) as 
compared to group RF(9.146±2.94).  
MS Saravana babu et al., (2014)( conducted a  prospective 
randomized study in 60 patients to evaluate the efficacy  and clinical profile 
of  Dexmedetomidine and Clonidine as an adjuvant to Ropivacaine, in 
epidural analgesia in spine surgeries by giving 20 ml of 0.2% Ropivacaine 
and 1 μg/kg of Dexmedetomidine (group RD) or 20 ml of 0.2% Ropivacaine 
and 2 μg/kg of Clonidine (group RC They observed that the addition of 
Dexmedetomidine to Ropivacaine as an adjuvant resulted in an earlier onset 
(7.33±1.76 min) of analgesia as compared to the addition of Clonidine 
(8.40±1.61 min 
 Ajay Kumar Anandan et al.,(2014)(30) conducted a study comparing 
Ropivacaine with Dexmeditomedine (RD) with Ropivacaine (R) in 30 patients 
and concluded that the onset was earlier in RD (3.60min.) compared with R 
group (4.60 min.). 
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In our study the onset of sensory analgesia was earlier in the RD group 
(5.93±0.700 min) than in the RF group (7.67±0.702 min). For onset of 
anaesthesia, the determinants are, diffusion through meningeal layers, 
penetration of neural tissue and distribution of the drug in various tissues. 
Dexmedetomidine being more lipophilic and having a favorable pKa produces 
an earlier onset of anagesia than fentanyl. 
PEAK EFFECT OF ANALGESIA 
In  Sukhminder jit singh bajwa et al  comparative study the time to 
reach peak analgesia was significantly shorter in RD group 
(13.38±4.48)compared to RF group(16.61±4.36 
The peak effect of analgesia in our study was  at 12.07min. for RD 
group and at 13.13min. for RF group which is statistically not significant 
(Pvalue-0.1330) in our study. 
DURATION OF ANALGESIA 
In  Sukhminder jit singh bajwa et al (19 comparative study  the mean 
duration of analgesia was longer (366.62±24.42min) in RD group than 
(242.16±3.86min) in  the RF group thus promising the superior block 
characteristics of RD group than RF group  
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In the study conducted by MS Saravana babu et al., (2014) the 
duration of  analgesia was also prolonged in Dexmedetomidine group 
(407.00±47.06 min) compared to Clonidine group (345.01±35.02).  
Mausumi Neogi et al.,  (24) (2010)  did a comparative study on 
paediatric patients undergoing elective inguinal herniotomy. They 
compared the efficacy of Clonidine 1 µg/kg and Dexmedetomidine 1 µg/kg 
as adjuvants to Ropivacaine for caudal analgesia.. They randomized the 
patients into 3 study groups, group R (Ropivacaine),  group C (Ropivacaine 
+ Clonidine), group D (Ropivacaine + Dexmedetomidine) and observed 
that, the mean duration of analgesia was 6.32±0.46 hours in group R, 
13.17±0.68 hours in group C and15.26±0.86  hours in group D. . They 
concluded that the addition of both Clonidine and Dexmedetomidine with 
Ropivacaine administered caudally significantly increased the duration of 
analgesia  
In Ajay Kumar Anandan et al.,(2014)(30)  study comparing 
Ropivacaine with Dexmeditomedine (RD) with Ropivacaine (R) in 30 
patients and concluded that  the  duration of analgesia was prolonged in RD 
(289min.) compared to R group (243 min). this results were correlated with 
our study.  
Sarabjit Kaur et al.,(33) (2014) conducted a  prospective, 
randomized double-blind study in 100 patients undergoing lower limb 
surgeries by randomly into groups receiving 150 mg of 0.75% Ropivacaine 
(Group A)  and 150 mg of 0.75% Ropivacaine with Dexmedetomidine (1 
μg/kg) (Group B). Two groups were compared with hemodynamic changes, 
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block characteristics which included time to onset of analgesia at T10, 
maximum sensory analgesic level, time to maximum sensory and motor 
block, regression at S1 dermatome and time to the first dose of rescue 
analgesia. Significant difference was observed in relation to the duration of 
sensory block (375.20 ± 15.97 min. in Group A and 535.18 ± 19.85 min. in 
Group B [P - 0.000]), duration of motor block (259.80 ± 15.48 min in 
Group A and 385.92 ± 17.71 min in Group B [P - 0.000]), duration of post-
operative analgesia (312.64 ± 16.21 min in Group A and 496.56 ± 16.08 
min in Group B [P < 0.001]) and consequently low doses of rescue 
analgesia in Group B (1.44 ± 0.501) as compared to Group A (2.56 ± 0.67). 
They concluded that Epidural Dexmedetomidine as an adjuvant to 
Ropivacaine associated with prolonged sensory and motor block, 
hemodynamic stability, prolonged postoperative analgesia and reduced 
demand for rescue analgesics when compared to plain Ropivacaine. These 
study also concluded that addition of  Dexmedetomidine to Epidural 
Ropivacaine prolongs the duration of action, and gives earlier onset of 
action of Ropivacaine.  
Ravi Prakash, B.B.Kushwaha, Shashibhushan, V.K.Bhatia, 
Girish Chandra and B.P.Singh et al did a comparative study of 
Bupivacaine 0.25% alone and with Fentanyl or Dexmedetomidine for 
percutaneous nephrolithotomy (pcnl) under epidural anaesthesia. The study 
was conducted on 75 patients who were randomly allocated in to three 
groups, Group A (n=25): patient receiving only 20 ml epidural 0.25% 
Bupivacaine. Group B (n=25): patient receiving 20 ml epidural0.25% 
Bupivacaine along with Fentanyl (1mcg/kg) and Group C (n=25): patient 
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receiving 20 ml epidural 0.25% Bupivacaine along with Dexmedetomidine 
(1mcg/kg).They observed that addition of Fentanyl and Dexmedtomedine 
prolongs the duration of analgesia. Dexmedetomidine was more effective in 
this respect. Time for 2 segment regression was 86.52 ± 9.07minutes for 
Group A,  120.00 ± 5.95 minutes for . Group B and 135.40 ± 9.57 minutes 
for Group C. 
In our study, the mean duration of analgesia as measured by the time 
taken for first rescue analgesic was significantly longer in RD group than RF 
group (349.80± 8.124min vs 298.20±4.77min).  The mean duration time was 
meaningfully more in Ropivacaine + Dexmedetomidine intervention group 
compared to Ropivacaine +  Fentanyl  intervention group by a mean time of 
52.20 minutes. This parameter show that the analgesic potentiating effect of 
Dexmedetomidine is more than  that of Fentanyl. 
HAEMODYNAMIC PARAMETERS. 
The study done  by Sukhminder jit singh bajwa et al(19)., showed 
hemodynamic stability with both RF and RD groups and there was no 
significant difference on statistical comparison. The mean dose of 
Mephentermine required was 11.8mg in RD and 8.mg in RF group in their 
study  
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The better hemodynamic stability and longer duration of sensory 
analgesia by dexmedetomidine has also been shown in the study of Gupta et 
al(26). They compared intrathecal administration of ropivacaine and 
ropivcaine/ dexmedetomidine and concluded that dexmedetomidine group has 
longer duration of analgesia with better hemodynamic stability. 
 In A comparative study in the post-operative spine surgeries by 
epidural Ropivacaine with Dexmedetomidine andRropivacaine with Clonidine 
for post-operative analgesia conducted by M S.Saranababu et al there was 
no significant difference of heart rate and mean arterial blood pressure in both 
the groups at the time of administration of drugs, but it started to decrease as 
evident at 30 min post-injection, there was a fall in both groups. There was a 
decreasing trend of heart rate and mean arterial pressure post-injection in 
both groups and this decrease was significant in the RC group compared with 
RD group (P<0.05) but none of the patient showed bradycardia or 
hypotension at any time. There was a decrease in mean respiratory rate in 
both the groups after giving the drug and the difference between the groups 
was statistically not significant (P>0.05) at different time intervals. None of 
the patient showed respiratory depression (<10/min) at any time 
In our study the mean Heart Rate(HR), Systolic blood pressure (SBP), 
Diastolic blood pressure(DBP) at varying time intervals showed significant 
difference between the  groups RD  and RF. Though there was decrease in HR 
,fall in SBP,DBP in both the groups, the mean HR was maintained between 
60-70/min (70.93) in RD group whereas it was maintained at 65-
80/min(79.13) in RF group. The mean SBP range from 127.07 mm Hg at 
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baseline to 120.40 mm Hg at the end of 12 hours in RD group and  mean  SBP 
ranging from 130.00 mm Hg at baseline to 120.80 mm Hg at the end of 12 
hours in RF group. The mean DBP range  from 77.93 mm Hg at baseline to 
79.03 mm Hg at the end of 12 hours in RD group and mean DBP range from 
79.60 mm Hg at baseline to 79.10 mm Hg at the end of 12 hours in RF group.  
VISUAL ANALOGUE SCORE 
VAS score between group RD was 1.79 and 2.31 in group RF and  
found to be significant during the whole period of observation (p<0.05) which 
correlated with study done by Gupta et al (26)., which showed the maximum 
visual analogue scale score for pain was less in group RD (4.4±1.4) as 
compared to group R (6.8±2.2)                                                                                           
RESCUE ANALGESIC REQUIREMENT%).  
In the study conducted by Sarabjit kaur et al.,(25)  there was 
significant delayed requirement of rescue analgesia (496.56 ± 16.08 min in 
Group A and 312.64 ± 16.21 min in Group B) and also reduced 24 h analgesic 
requirement (1.44 ± 0.501 in Group B and 2.56 ± 0.67 in Group A) with  
1μ/kg Dexmedetomidine added to Ropivacaine, which supports the analgesic 
efficacy of Dexmedetomidine as an epidural adjuvant. 
 In the study conducted by MS Saravana babu et al., (2014)(32) ,they 
compared the efficacy of Ropivacaine and Dexmedetomidine with 
Ropivacaine and Clonidine. They concluded that the need for IV rescue 
analgesics in both the groups was nil throughout the study period. The mean 
VAS score was higher in the Clonidine group at each time interval. They 
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concluded that, the epidural route provided adequate analgesia in spine 
surgeries and Dexmedetomidine is a better neuraxial adjuvant to Ropivacaine 
for providing early onset and prolonged post-operative analgesia and stable 
cardiorespiratory parameters 
In our study, the rescue analgesic requirement at the 6th hour was less 
in RD group(18.42%) compared to RF group (35.29%) . Similarly at 12th 
hour, it was 7.89% in RD group compared to RF group (21.57 early onset and 
prolonged  post-operative analgesia  and stable cardio respiratory parameters. 
RAMSAY SEDATION SCORE (RSS) 
The study conducted by Sukhminder jit singh bajwa et al.(19), showed 
that sedation in RDgroup was 2 in 38% , 3 in 48% whereas RF group had 
sedation score of 2 in 16% and 3 in 2%. in this study we can safely conclude 
that RSS score was significantly higher in RD group than RF group  
 Oriol-Lopez et al(24) conducted an observational study to find out the 
anxiolytic and sedative property of dexmedetomidine. Epidural 
dexmedetomidine 1µg/kg was given with lignocaine in 40 patients who 
underwent various abdominal surgeries. They used Ramsay sedation score and 
concluded that 90% of the study group were sedated to a score of 3 and 4 
from 15 to 90 minutes after drug administration.  
In our study, the mean sedation score at various time intervals was 
significant between these two groups. Majority of patients in RF group were 
sedated to score of 0,1 and 2 but in RD group the patients were sedated to  a 
score of 2 and 3.  
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COMPLICATIONS 
 Sukhminder jit singh bajwa et al.(19), showed nausea and vomiting 
as the predominant side effect in RF group, nausea and dry mouth in RD 
group and none in both the groups had respiratory depression. 
In our study, the predominant side effect was dry mouth , bradycardia 
and hypotension in RD group whereas in RF group it was Nausea and 
vomiting. In the RD group, 35.71% had dry mouth, bradycardia and 
hypotension 28%. Similarly the RF group 50% had Nausea and vomiting 
pruritis 33% as the presenting complication. There was no respiratory 
depression in RD group but 16.67% in RF group.  
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SUMMARY 
In this prospective randomized  study,    the analgesic efficacy of  
Dexmedetomidine 1µg/kg and Fentanyl 1µg/kg  which were  added to 15 ml 
of0.2%  Ropivacaine were compared  by giving these drugs through an 
epidural catheter in 60 patients undergoing elective spine surgeries. The 
efficacy of Dexmedetomidine versus Fentanyl as an adjuvant in epidural 
analgesia was studied. 
The following observations were made: 
1) The onset of sensory analgesia  was earlier in Ropivacaine 
Dexmedetomidine (RD) group (5.93±0.700 min) than Ropivacaine 
Fentanyl (RF) group (7.67±0.702 min). 
2) The peak effect of analgesia in our study was 12.07min. for RD group 
and 13.13min. for RF group which is statistically significant (Pvalue-
0.1330). 
3) The mean duration of analgesia as measured by the time taken  for first 
rescue analgesic was significantly longer in RD group than RF group 
(349.80± 8.124min vs 298.20±4.77min).   
4) Both the groups showed haemodynamic stability but the incidence of 
side effects such as hypotension and bradycardia were more in patients 
who received Dexmedetomidine , which was managed easily with inj 
Ephedrine 6mg and inj Atropine 0.6 mg. 
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5) Visual Analogue Scale score in group RD was 1.79 and 2.31 in group 
RF and it was  found to be significant during the whole period of 
observation (p<0.05)  
6) The rescue analgesic requirement was less with RD group when 
compared to RF group in the whole  study period. 
7) The administration of Dexmedetomidine epiduraly produced sedation 
that was arousable, for many hours when compared to  the plain 
Ropivacaine group. The mean sedation score at various time intervals 
was significant between these two groups.   
8) No episode of respiratory depression was noted in RD group compared 
to RF group. 
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CONCLUSION 
It can be concluded from this study that epidural route provided 
adequate effective analgesia in spine surgeries in terms of VAS score in both 
the groups. However, Dexmedetomidine seems to be a better alternative to 
Fentanyl as an epidural adjuvant as it  provides comparable , early onset and 
establishment of sensory anaesthesia, prolonged  analgesia in the post 
operative period, lesser consumption of post-operative rescue analgesics, 
stable haemodynamics  and much better sedation levels.  
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INFORMATION TO PARTICIPENTS 
Investigator                      : Dr. M. BHASKAR 
Name of the Participant :  
Title : A Prospective,  randomized  study comparing the efficacy and 
clinical profile of  Dexmedetomidine and  Fentanyl as an adjuvant to 
epidural  Ropivacaine for  post- operative pain relief in spine surgeries 
You are invited to take part in this research study. We have got 
approval from the IEC. Your are asked to participate because you satisfy the 
eligibility criteria .We want to compare and study the safety &efficacy of 
epidural block using  Ropivacaine  and  Dexmedetomidine with  Ropivacaine 
and  Fentanyl. 
What is the Purpose of the Research: 
For spine surgeries, epidural block with either  Ropivacaine and 
Dexmedetomidine or  Ropivacaine and  Fentanyl is given in post operative 
period via intra operatively placed epidural catheter. This study is done to 
compare the epidural block using the above mentioned drugs in patients who 
undergoing spine surgeries , with respect to, Onset of analgesia, Time of peak 
onset of analgesia and duration of  analgesia, The need of rescue analgesics. 
Post-operative  haemodynamics. 
The Study Design: 
All the patients in the study will be divided into two groups. 
Group1- post- operative epidural block with Ropivacaine and 
Dexmedetomidine. 
Group 2- post- operative  epidural block with  Ropivacaine  Fentanyl.  
Benefits 
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The epidural block provide adequate analgesia in spine surgeries in 
terms of VAS score and overall patient satisfaction and It avoids the need of 
IV/IM analgesics in post operative period in both groups.  In post operative 
period  provides stable haemodynamics . Problems associated with pain are 
avoided. 
Discomforts and risks 
There is no discomfort during block since the catheter is placed during 
intra operative period. Hypotension ,bradycardia may occur – emergency  
drugs are readily available. Vomiting  and sedation may occur. Since the drug 
will be given based on the calculated maximum allowable dose  the 
complication of    seizures does not occur. 
This intervention has been shown to be well tolerated as shown by 
previous studies. And if you do not want to participate you will have 
alternative of setting the standard treatment and your safety is our prime 
concern. 
Time : 
Date : 
Place : 
 
Signature / Thumb Impression of Patient 
Patient Name: 
 
Signature of the Investigator : ____________________________ 
Name of the Investigator : ____________________________ 
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PATIENT CONSENT FORM 
Title : A Prospective,  randomized  study comparing the efficacy and 
clinical profile of  Dexmedetomidine and  Fentanyl as an adjuvant to 
epidural  Ropivacaine for  post- operative pain relief in spine surgeries                                       
Study centre: Institute of Anaesthesiology and Critical Care, 
Rajiv  Gandhi Govt. General Hospital, Madras Medical College, Chennai-3.  
Participant Name :     Age/Sex:   I.P.No: 
I confirm that I have understood the purpose of procedure for the above 
study . I have the opportunity to ask the question and all my questions and 
doubts have been answered to my satisfaction. 
I have been explained about the pitfall in the procedure.  I have been 
explained about the safety, advantage and disadvantage of the technique. 
I understand that my participation in the study is voluntary and that I 
am free to withdraw at anytime without giving any reason. 
I understand that investigator , regulatory authorities and the ethics 
committee will not need my permission to look at my health records both in 
respect to current study and any further research that may be conducted in 
relation to it, even if I withdraw from the study . I understand that my identity   
will not be revealed in any information released to third parties or published , 
unless as required under the law . I agree not to restrict the use of any data or 
results that arise from the study . 
Signature / thumb impression of patient  
Time: 
Date: 
Place:      Patient Name: 
Signature of the investigator: 
Name of the investigator: 
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PROFORMA 
Date:         Roll No: 
Name:     Age/Sex:   IP No: 
Diagnosis 
Surgical Procedure Done 
Ht:     CVS:     HB: 
Wt:     RS:    
Airway:  MMS:  TMD, IID:  Dentition: 
Pre Op Assessment 
History: Any co-morbid illness 
H/o. Previous surgeries 
Measures of Study outcome 
HR SBP DBP MAP  SPO2 
Pre OP 
Intraoperative Vital Signs 
Dose of Opoid Used 
Complications in intra operative period 
Complications in post extubation Period 
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BY INTRAOPERATIVELY PLACED EPIDURAL CATHETERPATIENT 
OUTCOME MEASURES 
Time 
(min) VAS 
Pulse 
Rate 
Systolic 
BP 
Diastolic 
BP SPO2 RR 
Side Effects 
(Tick) 
0        
 
 Nausea 
 Vomiting 
 SPO2  
 Motor 
Blockade 
 Deep 
Sedation 
 Shivering 
 Hypotension 
 Requirement 
of rescue 
Analgesics 
2  
4  
6  
10  
12       
14  
16  
18  
20  
22       
24  
26  
28  
30  
60 (1Hr)       
90       
120 (2Hr)       
150       
180 (3Hr)       
210       
240 (4Hr)       
270       
300 (5Hr)       
330       
360 (6Hr)       
390       
420 (7Hr)       
450       
480 (8Hr)       
510       
540 (9Hr)       
570       
600 
(10Hr) 
      
720(12 
Hr) 
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